Russell Investments Group’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.1K Buy
+258
New +$2.1K ﹤0.01% 3585
2024
Q4
Sell
-84
Closed -$414 3758
2024
Q3
$414 Buy
+84
New +$414 ﹤0.01% 3587
2023
Q2
Sell
-238,836
Closed -$902K 3500
2023
Q1
$902K Hold
238,836
﹤0.01% 2025
2022
Q4
$1.55M Sell
238,836
-52,934
-18% -$343K ﹤0.01% 1746
2022
Q3
$2.59M Sell
291,770
-5,178
-2% -$46K 0.01% 1408
2022
Q2
$2.96M Buy
296,948
+4,578
+2% +$45.6K 0.01% 1374
2022
Q1
$3.38M Sell
292,370
-1,218
-0.4% -$14.1K 0.01% 1366
2021
Q4
$3.26M Sell
293,588
-246,800
-46% -$2.74M 0.01% 1520
2021
Q3
$4.98M Sell
540,388
-214,540
-28% -$1.98M 0.01% 1257
2021
Q2
$8.49M Sell
754,928
-425,801
-36% -$4.79M 0.01% 1020
2021
Q1
$12.5M Sell
1,180,729
-245,537
-17% -$2.6M 0.02% 822
2020
Q4
$15.5M Sell
1,426,266
-1,392,984
-49% -$15.1M 0.03% 626
2020
Q3
$27.4M Sell
2,819,250
-214,332
-7% -$2.08M 0.06% 362
2020
Q2
$24.2M Buy
3,033,582
+225,553
+8% +$1.8M 0.05% 398
2020
Q1
$24.4M Sell
2,808,029
-57,846
-2% -$503K 0.06% 329
2019
Q4
$32.4M Buy
2,865,875
+665,387
+30% +$7.52M 0.06% 366
2019
Q3
$23.9M Buy
2,200,488
+407,935
+23% +$4.43M 0.05% 463
2019
Q2
$16.8M Buy
1,792,553
+1,578,723
+738% +$14.8M 0.03% 631
2019
Q1
$2.63M Buy
+213,830
New +$2.63M ﹤0.01% 1574
2018
Q4
Sell
-16,500
Closed -$237K 2986
2018
Q3
$237K Sell
16,500
-322,241
-95% -$4.63M ﹤0.01% 2613
2018
Q2
$5.05M Sell
338,741
-464,029
-58% -$6.92M 0.01% 1276
2018
Q1
$10.5M Buy
802,770
+420,108
+110% +$5.48M 0.02% 954
2017
Q4
$4.63M Buy
382,662
+173,055
+83% +$2.09M 0.01% 1386
2017
Q3
$2.71M Buy
209,607
+26,767
+15% +$347K ﹤0.01% 1604
2017
Q2
$2.72M Buy
182,840
+26,794
+17% +$398K ﹤0.01% 1561
2017
Q1
$1.87M Buy
156,046
+5,538
+4% +$66.4K ﹤0.01% 1788
2016
Q4
$2.1M Buy
+150,508
New +$2.1M ﹤0.01% 1771